secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0000950157-23-001058
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher to acquire Olink for $26/share, ~$3.1B total
----------------------------------------------------------

- Cash tender offer at $26/ADS, ~74% premium to Oct 16 close; transaction values Olink at ~$3.1B including ~$143M net cash.
- Expected close mid-2024; support agreements from >63% of Olink shareholders including largest shareholder Summa Equity.
- Olink projected >$200M revenue in 2024 with mid-teens organic growth; expected to be part of Thermo Fisher's Life Sciences Solutions segment.
- Transaction expected to be $0.17 dilutive to adjusted EPS in first full year, but $0.10 accretive excluding financing and equity comp.
- Thermo Fisher expects ~$125M adjusted operating income from synergies by year five.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000095015723001058/0000950157-23-001058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000095015723001058/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000950157-23-001058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer